The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

An FDA panel has recommended that the risky and controversial MS drug Tysabri be returned to the market. The panel argued that the decision to use the drug should be made by the doctor and the patient, in spite of evidence that the drug causes a deadly brain disease. If the FDA accepts the panel’s recommendation, it would be only the second time a drug was returned to the market after having been removed for safety reasons.

Comments are closed.

Of Interest